Xponance’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.9M | Buy |
62,600
+13,431
| +27% | +$5.98M | 0.23% | 68 |
|
|
2025
Q1 | $23.8M | Buy |
49,169
+662
| +1% | +$321K | 0.23% | 71 |
|
|
2024
Q4 | $19.5M | Buy |
48,507
+539
| +1% | +$217K | 0.18% | 88 |
|
|
2024
Q3 | $22.3M | Buy |
47,968
+273
| +0.6% | +$127K | 0.22% | 75 |
|
|
2024
Q2 | $22.4M | Sell |
47,695
-11,371
| -19% | -$5.33M | 0.23% | 67 |
|
|
2024
Q1 | $24.7M | Buy |
59,066
+413
| +0.7% | +$173K | 0.26% | 62 |
|
|
2023
Q4 | $23.9M | Buy |
58,653
+562
| +1% | +$229K | 0.29% | 61 |
|
|
2023
Q3 | $20.2M | Buy |
58,091
+689
| +1% | +$240K | 0.27% | 61 |
|
|
2023
Q2 | $20.2M | Sell |
57,402
-69
| -0.1% | -$24.3K | 0.27% | 63 |
|
|
2023
Q1 | $18.1M | Buy |
57,471
+1,331
| +2% | +$419K | 0.26% | 69 |
|
|
2022
Q4 | $16.2M | Buy |
56,140
+4,870
| +9% | +$1.41M | 0.26% | 75 |
|
|
2022
Q3 | $14.8M | Buy |
51,270
+3,772
| +8% | +$1.09M | 0.29% | 63 |
|
|
2022
Q2 | $13.4M | Buy |
47,498
+20,198
| +74% | +$5.69M | 0.27% | 68 |
|
|
2022
Q1 | $7.12M | Buy |
27,300
+533
| +2% | +$139K | 0.12% | 147 |
|
|
2021
Q4 | $5.88M | Buy |
26,767
+3,078
| +13% | +$676K | 0.09% | 189 |
|
|
2021
Q3 | $4.3M | Sell |
23,689
-1,226
| -5% | -$222K | 0.08% | 201 |
|
|
2021
Q2 | $5.02M | Sell |
24,915
-13,243
| -35% | -$2.67M | 0.09% | 180 |
|
|
2021
Q1 | $8.2M | Sell |
38,158
-93
| -0.2% | -$20K | 0.17% | 111 |
|
|
2020
Q4 | $9.04M | Buy |
38,251
+836
| +2% | +$198K | 0.2% | 91 |
|
|
2020
Q3 | $10.2M | Buy |
37,415
+22
| +0.1% | +$5.99K | 0.25% | 75 |
|
|
2020
Q2 | $10.9M | Buy |
+37,393
| New | +$10.9M | 0.28% | 69 |
|